Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.